Sustainability Is an Integral Part of Roche's Business Strategy

Roche has been named the most sustainable company in the "Pharmaceuticals, Biotechnology and Life Sciences" industry sector by the Dow Jones Sustainability Index (DJSI) for the tenth consecutive year. The index, which is based on an in-depth analysis of companies' economic, social and environmental performance, serves as a benchmark for investors who factor sustainability into their portfolios. Through its excellence sustainability strategy, which has become fully integrated with company operations and culture, Roche demonstrates superior performance particularly in the Marketing Practices, Environmental and Social Reporting, and Health Outcomes Contribution categories of the index. Roche CEO Severin Schwan, expressing pride that the company's sustainability efforts have delivered leadership for the tenth time, said: "As Roche, our most important contribution to society is developing medicines and diagnostic tools that significantly improve people's lives. The open and constructive dialogue we establish with other companies, universities, doctors and patients plays a fundamental role in understanding the needs of our health sector stakeholders and gives us the ability to work together to deliver more targeted medical solutions more rapidly."

Roche and Sustainability

Sustainability has been an integral part of Roche's operations for more than 120 years. Taking a holistic approach to sustainability management, Roche's company strategy focuses not only on increasing access to healthcare but also on continuous improvement in areas such as social responsibility, environmental protection, supply chain sustainability, and attracting and retaining new talent. In this way, Roche not only creates value for society but also ensures sustainable economic growth for itself.